期刊文献+

难治性高血压诊断和治疗分析 被引量:2

Difficult hypertension diagnosis and the treatment analyzes
原文传递
导出
摘要 目的:探讨难治性高血压(RH)的病因,总结临床诊治经验。方法:回顾性分析我院收治的46例RH患者的临床资料。结果:原发性高血压有40例(87.0%),继发性高血压6例(13.0%);治疗依从性差(56.5%)和生活方式不良(17.4%)是主要原因,其次为治疗方案不合理(13.0%)和白大衣高血压(8.7%)。联合使用3种以上抗高血压药物,足剂量给药,进行正规化治疗后,血压控制在140/90mmHg以下者38例(82.6%),5例(10.9%)控制在150/95mmHg以下;3例(6.5%)继发性高血压因没有根除原发病,血压未达标。结论:RH要根据病史以及检查结果分析原因,治疗时联合使用3种以上抗高血压药物,足剂量给药,在提高依从性的基础上,改善生活方式、制定合理降压方案、个体化实施降压,以提高控制率。 Objeetive..The discussion difficult hypertension (RH) cause of disease, summarizes the clinical diagnosis experience. Methods: The re-blew analyzes my courtyard admitting 46 example RH patient's clinical material. Results:The primary hypertension has 40 examples (87.0K), sequential hypertension 6 examples (13.0%); The treatment compliance difference (56.5%) and the life style not good (17.4%) is the primary cause,next for treatment plan unreasonable (13.0%) and white coat hypertension (8. 7 %). Jointly uses 3 kind of above anti--hypertension medicines, the full dosage gives the medicine,after carries on the standardized treatment,blood pressure control below 140/90mmHg 38 examples (82.6%), 5 examples (10.9%) control below 150/95mmHg; Because 3 example (6.5 %) sequential hypertension has not eradicated the the primary affection,the blood pressure standards. Conelusion:RH must act according to the medical history as well as the inspection result analysis reason,when the treatment jointly uses 3 kind of above anti--hypertension medicines, the full dosage gives the medicine, in enhancement compliance foundation, improvement life style, formulation reasonable voltage dropping resistor plan, individuation implementation voltage dropping resistor, en- hances the inverse amplification factor.
作者 徐亚琼
出处 《按摩与康复医学》 2010年第15期19-20,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 难治性高血压 诊断 治疗 治疗依从性 The difficult hypertension Diagnosis Treatment Treatment compliance
  • 相关文献

参考文献4

二级参考文献37

  • 1张维忠.顽固性高血压的评估与处理[J].内科急危重症杂志,2004,10(2):60-61. 被引量:17
  • 2Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 2007, 28: 1462-1536.
  • 3Moser M, Setaro JF. Resistant or difficult-control hypertension. N Engl J Med, 2006, 355:385-392.
  • 4The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker diuretic : the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 2002, 288:2981-2997.
  • 5Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich), 2002, 4:393-404.
  • 6Black HR, EUiott WJ, Grandits G, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA, 2003, 289:2073-2082.
  • 7Julius S, Kjeldsen SE, Brunner H, et al. VALUE trial:Long-term blood pressure trends in 13, 449 patients with hypertension and high caridovaseular risk. Am J Hypertens, 2003, 16:544-548.
  • 8Hyman D J, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med, 2001, 345.479-486.
  • 9Calhoun DA, Nishizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension, 2002, 40:892-896.
  • 10Aucott L, Poobalan A, Smith WC, et al. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension, 2005, 45: 1035- 1041.

共引文献601

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部